title: Early phacoemulsification in diabetic cataract for early recognition and management of diabetic macular oedema.
abstract: OBJECTIVE
  To get optimal visualization of fundus by early phacoemulsification in diabetic cataract for early recognition and management of diabetic macular oedema.
  
  
  METHODS
  Interventional study.
  
  
  METHODS
  Ophthalmology Unit III, Sindh Government Lyari General Hospital and Dow University of Health Sciences and Al-Noor Eye Hospital, Karachi, from July 2008 to June 2009.
  
  
  METHODS
  Patients with uncontrolled type-II diabetes mellitus of more than 10 years of duration were selected. Patients with clinical significant macular oedema (CSME), non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) were excluded. Follow-up was done on day 1, 1 week, 1 month, 3 months and 6 months.
  
  
  RESULTS
  The male to female ratio was 1:1.44. Out of 218 patients; 129 (59.2%) were males and 89 (40.8%) were females. CSME was found in 82 patients (37.6%) at first postoperative week which declined to 29 cases (13.3%) at first month follow-up. Three subjects developed mild to moderate NPDR. In majority of the subjects, best corrected visual acuity (BCVA) gradually improved in each subsequent follow-up visit.
  
  
  CONCLUSIONS
  Early phacoemulsification in diabetic cataract offers optimal posterior pole visualization and clears the ambiguity of decreased vision either caused by cataract or macular oedema. Uncomplicated phacoemulsification does not accelerate diabetic macular oedema or retinopathy provided glycemic control and co-morbids are well addressed.
authors.affiliation: Ophthalmology Unit II, Dow University of Health Sciences, Civil Hospital, Karachi. nosherwan@cyber.net.pk
authors.forename: Shahid
authors.initials: S
authors.lastname: Wahab
authors.forename: Khowaja
authors.initials: K
authors.lastname: Faiz-ur-Rab
authors.forename: Lakhani
authors.initials: L
authors.lastname: Das Hargun
mesh_terms: D000328:Adult; D000368:Aged; D002386:Cataract / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000601:surgery; D003930:Diabetic Retinopathy / Q000150:complications* / Q000503:physiopathology; D042241:Early Diagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019654:Lens Implantation, Intraocular / Q000379:methods; D008269:Macular Edema / Q000150:complications*; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification / Q000009:adverse effects / Q000379:methods*; D013997:Time Factors; D016896:Treatment Outcome; D014792:Visual Acuity